Virtual World Preceptorship on Luteinizing Hormone in ART
2 July - 30 November 2021

Overview

The role of luteinizing hormone (LH) during folliculogenesis has intrigued the scientific and medical community for at least three decades. There is an emerging galaxy of research to explore concerning this enigmatic subject. The availability of recombinant drugs now offers, for the first time, the opportunity to examine the role of follicle stimulating hormone and LH separately. An emerging topic during last year’s conference was LH supplementation to improve the outcome in a subgroup of low prognosis patients selected according to POSEIDON classification.

This new virtual preceptorship is designed to explore the role of luteinizing activity during folliculogenesis and beyond. The virtual preceptorship will feature and summarise educational material released during the last edition of the Virtual World Conference on Luteinizing Hormone in ART. In addition, three live sessions (practical session in three ‘host’ clinics) will be streamed live and each session will provide the opportunity for more practical in-depth learning. Each live session will engage a group of participants that has prepared case studies and questions. The chairs will present selected case studies/questions focusing on LH and ART, and discuss them live together with the host Clinic team. Prior to each live session, relevant MCQ and literature will be shared with participants. The pre-live exercises will guide discussion on the optimal clinical management for each case.

During the preceptorship, the participant can also visit the chat room to discuss interesting topics and debate with colleagues. The virtual preceptorship doesn’t stop there – A library with a collection of recent articles related to the program will be freely available to all participants. We hope you find this learning experience, on the role of luteinizing hormone in ART, to benefit your on-going education. We look forward to welcoming you to this next exploration.

Learning Objectives

Target Audience

The programme is intended for clinicians, embryologists, andrologists, scientists, and managers working in ART who wish to update their knowledge of advanced techniques and scientific innovations and understand best practices using evidence-based models of care.

Accreditation

The live sessions has been submitted for CME accreditation to EACCME® (European Accreditation Council for Continuing for Medical Education

Language

The official language of the activity is English. Simultaneous translation (from/to English/Chinese/French/Spanish) has been provided.

Educational Format

The virtual preceptorship will feature:

6 Video lectures

that were released throughout the last Virtual World Conference on Luteinizing Hormone in ART: A New Galaxy is Born! In 2020.

6 Scribing Mapping

Of the video lectures that were released throughout the last Virtual World Conference on Luteinizing Hormone in ART: A New Galaxy is Born!

3 live sessions

(practical session) will be streamed live and each session will provide the opportunity for more practical in-depth learning.

Chat room

to discuss interesting topics and debate with colleagues.

Diploma signed by the Chair

and certificate for attending the three live sessions.

Chairs

Carlo Alviggi

Naples, Italy
Biography

Robert Fisher

Hamburg, Germany
Biography

Sandro Esteves

Campinas, Brazil
Biography

Peter Humaidan

Aarhus, Denmark
Biography

Co-Chairs

Budi Wiweko

Universitas Indonesia Pondok Indah Hospital IVF Clinic Jakarta, Indonesia
Biography

Hakan Yarali

Hacettepe University Anatolia IVF and Women’s Health Center Ankara, Turkey
Biography

Faculty

Federico II University
Naples, Italy

Federico II University
Naples, Italy

Federico II University
Naples, Italy

Androfert – Andrology and Human Reproduction Clinic
Campinas, Brazil

Fertility Centre Hamburg
Hamburg, Germany

Fertility Clinic, Skive Regional Hospital
Faculty of Health, Aarhus University
Aarhus, Denmark

Laboratory Director
Anatolia IVF and Women’s Health Centre
Ankara, Turkey

Obstetrics and Gynecology
Anatolia IVF and Women’s Health Centre
Ankara, Turkey

Pondok Indah Hospital IVF Clinic
Jakarta, Indonesia

Federico II University
Naples, Italy

Pondok Indah Hospital IVF Clinic
Jakarta, Indonesia

Universitas Indonesia
Pondok Indah Hospital IVF Clinic
Jakarta, Indonesia

Hacettepe University
Anatolia IVF and Women’s Health Center
Ankara, Turkey

RS Pondok Indah IVF Center
Jakarta, Indonesia

Preliminary Programme

Agenda

Live Session Videos

Play Video
Play Video
Play Video

Video Lectures

Play Video
Play Video
Play Video
Play Video
Play Video
Play Video
Play Video
Play Video

General Information

CME Provider

Med.E.A – Medical Education Academy

Chloé Xilinas, Programme and Relations Manager
in Medical Education

Funding

Med.E.A Srl educational programs are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products.
These views are the responsibility of the named speakers and do not represent an endorsement or recommendation on the part of Med.E.A. Srl. Our educational activities are supported by independent grants from the Healthcare business of Merck KGaA, Darmstadt, Germany; FUJIFILM EUROPE GMBH, Fujifilm Italia S.p.A., FUJIFILM France S.A.S., Androfert Andrology & Human Reproduction Clinic; MVZ Fertility Center Hamburg GmbH; University of North Carolina at Chapel Hill; Reproductive Medicine Agency (Nova Clinic)

· Carlo Alviggi ·

Carlo Alviggi earned his MD degree in 1994, from the Faculty of Medicine of the University of Naples “Federico II” in Naples, Italy; he specialized in obstetrics and gynaecology in 1998, and gained a PhD in 2001, from the same university. During his career, he collaborated with: The Imperial College of London, in London, UK; the Laboratory of Immunology of the Italian National Research Council in Naples; and the Autoimmunity and Tolerance Laboratory of the University of California in Los Angeles, CA, USA. This network resulted in various publications, some of which concern new hypotheses on the pathogenesis of pelvic endometriosis. He is now an associate professor in reproductive medicine at the Fertility Unit of the University of Naples “Federico II”. Professor Alviggi’s current research interests are the role of luteinizing hormone (LH) in folliculogenesis; the use of LH-containing drugs in patients undergoing ovarian controlled stimulation for IVF; the pathogenesis of pelvic endometriosis; oncofertility; reproductive endicrinology and the genetics of human reproduction. He has participated in several national and international (phase 2 and 3) multicentric, prospective randomized trials. Professor Alviggi has published extensively and has been invited to lecture at over 200 international meetings dealing with reproductive medicine and gynaecological endocrinology; he is also starter and co-founder of the Poseidon group, an international collaborative network dedicated to low prognosis patients in Assisted Reproductive Technology and vice-President of the “Società Italiana di Fertilità e Sterilità – Medicina della Riproduzione”.

· Robert Fischer ·

Robert Fischer is the founder and Medical Director of the Fertility Center Hamburg (FCH) in Hamburg, Germany. Dr Fischer trained in obstetrics and gynaecology at the University Hospital of Münster, Germany, from 1979 to 1982 and at the Queen’s Medical Centre, University of Nottingham, UK. In 1983, Dr Fischer pioneered the first German outpatient IVF unit in Hamburg and became its Medical Director. The unit moved to a new location in 1998, and its name was changed to the “Fertility Center Hamburg”.

In July 1998, the Fertility Center Hamburg was one of the first centres, both in Germany and worldwide, to introduce quality management, and it was certified according to the ISO 9001 and accredited for IVF laboratories (ISO 17025). Dr Fischer’s main research interests are in the development of stimulation protocols, luteinizing hormone supplementation, and gonadotropin-releasing hormone agonist triggering, as well as further development of quality management systems in IVF centres. He is a founding member of the European Society of Human Reproduction and Embryology (ESHRE); a founding member of the POSEIDON (Patient Oriented Strategies Encompassing IndividualizeD Oocyte Number) group);  Member of the  Scientific Committee of Excellence in Medical Education (EXCEMED- formerly the Serono Symposia International Foundation) and Scientific director of  Med.E.A.( Medical Education Academy)

· Sandro C. Esteves ·

Sandro Esteves, MD., Ph.D. is a board-certified urologist and consultant in assisted reproduction with over 25 years of clinical experience in all areas of reproductive medicine, with specialization in male reproduction.

He is listed by Expertscape among the top three world experts in the areas of male infertility, azoospermia, varicocele, and sperm retrieval techniques. Sandro has been also included in the list of the world’s most influential scientists.

He is the Founder and Medical Director of the ANDROFERT Andrology & Human Reproduction Clinic, in Campinas, Brazil. Dr. Esteves established the first Brazilian Fertility Clinic with a primary focus on male infertility, as well as the very first to introduce quality management as per the ISO 9001 standards and IVF cleanroom technology (ISO 14644-1).

Sandro is also a Collaborating Professor of Urology at the University of Campinas (UNICAMP, Brazil) and Honorary Professor of Reproductive Medicine at Aarhus University (Denmark). Dr. Esteves received his Master’s in Surgery from the University of Campinas Medical School and his Ph.D. in Urology from the Federal University of São Paulo Medical School. His post-doctoral training was at the American Center for Reproductive Medicine at the Cleveland Clinic in the United States. He has received many research grants and awards from national and international societies.

Prof. Esteves is the author of 10 textbooks in the fields of infertility and reproductive medicine. He was also the co-editor of several Journal Supplements and has published over 400 hundred scientific papers in journals like Lancet, Nature, Human Reproduction Update, Human Reproduction, Fertility and Sterility, etc. His current Hirsch index (h-index) is 63 while his citation count is over 12K. He is a member of ‘Faculty Opinions’ in the area of reproductive endocrinology & infertility. Dr. Esteves is Associate Editor of Frontiers in Endocrinology (Reproduction), Andrology, International Brazilian Journal of Urology, Regional Editor of the Société Internationale d’Urologie Journal, an editorial board member of Nature Reviews Urology, and a dozen of other peer-reviewed scientific journals. He is also a co-founder of the POSEIDON group and currently serves as a Chair of the Male Infertility Section of the WHO Infertility Guidelines Development Group.

Dr. Esteves is a very much requested speaker and presents over 50 lectures annually. He also regularly conducts infertility workshops, provides consulting services in the area of quality management for ART Clinics,

· Peter Humaidan ·

Professor Peter Humaidan is a specialist in reproductive endocrinology, professor at The Fertility Clinic Skive Regional Hospital, Aarhus University, Denmark and Honorary professor at Odense University, Denmark. During his scientific work he has primarily focused on developing individualized treatment protocols for the infertile patient. His doctoral thesis (DMSc) explored the role of LH during the follicular and luteal phases in controlled ovarian stimulation. His main fields of interest are triggering of ovulation with GnRH agonist, use of GnRH antagonists, and OHSS prevention. He is the founder of the international society “The Copenhagen GnRHa Triggering Workshop Group” and co-founder of the POSEIDON group which suggested a new stratification of the poor responder patient. Moreover, he is a past board member of the ESHRE SIG Endocrinology Group. He authored and co-authored 187 + articles (H-index 44, Google Scholar) in international peer reviewed journals as well as the Danish guidelines for OHSS prevention and chapters in textbooks. Peter Humaidan has a wide international scientific network and is frequently invited as a speaker at international conferences.

· Hakan Yarali ·

Professor Hakan Yaralı, MD is the Clinical Director of Anatolia IVF Center and Professor at Hacettepe University, Ankara, Turkey. Following medical school and residency training in OB/GYN at Hacettepe University, Hakan Yaralı did his clinical fellowship at University of British Columbia, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Vancouver, Canada during 1991-1992. He has authored more than 120 articles, eight book chapters and delivered over 50 lectures worldwide. He has roles as a reviewer in top-ranked journals. He was the former president of Turkish Society of Reproductive Medicine (TSRM). He has organized several national, international meetings and preceptorship programs training clinicians from diverse countries. He is directing Anatolia IVF, which is one of the busiest IVF centers in Turkey, performing over 1600 cycles annually. His special interests are clinical IVF-all aspects.